−2.24 PLN
−28.37 M PLN
100.00 PLN
11.57 M
About MOLECURE
Sector
CEO
Marcin Jan Szumowski
Headquarters
Warsaw
Website
Founded
2012
ISIN
PLONCTH00011
FIGI
BBG00K9D8XX0
Molecure SA engages in the discovery and development of small molecules for the treatment of unmet medical needs. It offers a platform of distinct small molecule programs targeting chitinases and chitinase-like-proteins, with potential utility in diverse inflammatory and fibrotic diseases. The company was founded by Stanislaw Wieslaw Pikul and Adam Golebiowski on March 12, 2012 and is headquartered in Warsaw, Poland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MOC is 9.56 PLN — it has decreased by −4.56% in the past 24 hours. Watch MOLECURE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange MOLECURE stocks are traded under the ticker MOC.
MOC stock has fallen by −7.65% compared to the previous week, the month change is a −8.54% fall, over the last year MOLECURE has showed a −49.09% decrease.
We've gathered analysts' opinions on MOLECURE future price: according to them, MOC price has a max estimate of 20.00 PLN and a min estimate of 17.60 PLN. Watch MOC chart and read a more detailed MOLECURE stock forecast: see what analysts think of MOLECURE and suggest that you do with its stocks.
MOC stock is 2.65% volatile and has beta coefficient of 0.60. Track MOLECURE stock price on the chart and check out the list of the most volatile stocks — is MOLECURE there?
Today MOLECURE has the market capitalization of 158.59 M, it has decreased by −7.65% over the last week.
Yes, you can track MOLECURE financials in yearly and quarterly reports right on TradingView.
MOC net income for the last quarter is −6.26 M PLN, while the quarter before that showed −7.73 M PLN of net income which accounts for 18.93% change. Track more MOLECURE financial stats to get the full picture.
No, MOC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 111.00 employees. See our rating of the largest employees — is MOLECURE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOLECURE EBITDA is −36.63 M PLN, and current EBITDA margin is −32.13 M%. See more stats in MOLECURE financial statements.
Like other stocks, MOC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOLECURE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOLECURE technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOLECURE stock shows the sell signal. See more of MOLECURE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.